The expression level of SLC7A11 was also positively related to the stromal score, the immune score, and the ESTIMATE score, as well as to four types of small-molecule drugs (i.e., gemcitabine, AZD7762, bortezomib, and vinorelbine), while the gene was negatively related to tumor purity and to five types of small-molecule drugs (i.e., AZD6482, cisplatin, erlotinib, gefitinib, and nilotinib). This evidence concerns the gene SLC7A11 and neoplasm.